Symeres

Turning a promising idea into an IND-ready program takes expertise across multiple disciplines. Symeres brings discovery and development capabilities together to help you progress from early research towards the clinic.

Multiple CROs. Multiple handoffs. Multiple opportunities for your program to lose time and momentum. Symeres brings chemistry, biology, ADME, and CMC together within one integrated program, with one team connecting the science from discovery through development. Less coordination. Fewer gaps. More focus on moving your drug forward.

Your drug discovery program shouldn’t feel like a relay race between different providers. At Symeres, chemistry, biology, and ADME can work together within one integrated project structure, helping teams stay aligned and your program keep moving.

Looking for new compounds to screen? SymeGold gives you access to 81,500 sp3-high, spirocyclic-rich compounds for hit discovery, with hits and associated IP yours to keep.

Every handoff creates another opportunity for delays, lost context, and added complexity. With integrated chemistry, biology, ADME, and development capabilities, Symeres helps reduce unnecessary handoffs and keep your program moving with greater continuity.

Finding a promising hit is only the beginning. What happens next matters. With SymeGold, when your screen identifies a hit, it’s removed from the library. The compound is yours to take forward, along with the associated IP. No competing screens. No shared hit. Your discovery, your opportunity.